Chemotherapy for gastric cancer in Japan Masahiko Nishiyama Introduction to Review Articles 14 June 2008 Pages: 191 - 192
Chemotherapy for metastatic disease: review from JCOG trials Narikazu Boku Review Article 14 June 2008 Pages: 196 - 200
Chemotherapy for advanced gastric cancer: ongoing phase III study of S-1 alone versus S-1 and docetaxel combination (JACCRO GC03 study) Masashi Fujii Review Article 14 June 2008 Pages: 201 - 205
Challenges in predicting the clinical outcome in S-1-based chemotherapy for gastric cancer patients Wataru IchikawaYasutsuna Sasaki Review Article 14 June 2008 Pages: 206 - 211
Challenge for a better combination with basic evidence Kazuhiro YoshidaKazuya YamaguchiYoshihiro Tanaka Review Article 14 June 2008 Pages: 212 - 219
Epidemiological study of malignant tumors in the oral and maxillofacial region: survey of member institutions of the Japanese Society of Oral and Maxillofacial Surgeons, 2002 Yasunori AriyoshiMasashi ShimaharaKanichi Seto Cancer Statistics 14 June 2008 Pages: 220 - 228
Free-to-total prostate-specific antigen (PSA) ratio contributes to an increased rate of prostate cancer detection in a Japanese population screened using a PSA level of 2.1–10.0 ng/ml as a criterion Yoshitomo KoboriYasuhide KitagawaMikio Namiki Original Article 14 June 2008 Pages: 229 - 232
Feasibility and effectiveness of postoperative adjuvant concurrent chemoradiation therapy in Japanese patients with high-risk early-stage cancer of the uterine cervix Kiyosumi ShibataHiroaki KajiyamaFumitaka Kikkawa Original Article 14 June 2008 Pages: 233 - 238
Current trends in diagnostic and therapeutic principles for prostate cancer in Japan Koji OkiharaTakumi ShiraishiTsuneharu Miki Original Article 14 June 2008 Pages: 239 - 243
Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202) Toshirou NishidaKuniaki ShiraoSeiichi Hirota Original Article 14 June 2008 Pages: 244 - 251
Evaluation of circulating tumor cells in patients with breast cancer: multi-institutional clinical trial in Japan Hiroshi YagataSeigo NakamuraAkemi Kataoka Original Article 14 June 2008 Pages: 252 - 256
Clinical outcome and prognostic survival factors in patients with advanced renal cell carcinoma treated with very low-dose interleukin-2, interferon-α, and tegafur-uracil: a single-institution experience Minoru KobayashiHitoshi IkedaTatsuo Morita Original Article 14 June 2008 Pages: 257 - 262
Placental-site trophoblastic tumor with PET scan-detected surgically treated lung metastasis Lucybeth NievesJames HoffmanJoel I. Sorosky Case Report 14 June 2008 Pages: 263 - 265
Endometrioid adenocarcinoma arising in adenomyosis: elucidation by periodic magnetic resonance imaging evaluations Kenichi MotoharaHironori TashiroHidetaka Katabuchi Case Report 14 June 2008 Pages: 266 - 270
Cardiac metastasis from renal cell carcinoma without inferior vena involvement: a review of the literature based on a case report. Two different patterns of spread? Fable ZustovichFedra GottardoGiuseppe Cartei Case Report 14 June 2008 Pages: 271 - 274
Benign multicystic peritoneal mesothelioma in a cesarean-section scar presenting as a fungating mass Juan E. CuartasAditya V. MaheshwariJ. David Pitcher Jr. Case Report 14 June 2008 Pages: 275 - 278
No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in Japan Toshiaki SaekiMuneo SanoShigemitsu Takashima Erratum 14 June 2008 Pages: 279 - 279
